We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




MRI CryoProbe Enables Preclinical MRI of Mice at 60-Micrometer Spatial Resolution

By HospiMedica International staff writers
Posted on 05 Sep 2008
A magnetic resonance imaging (MRI) CryoProbe provides an increase in sensitivity of approximately a factor of 2.5x in small animal in vivo MRI. More...
This enables very high three-dimensional (3D) isotropic spatial resolution down to 60 µm, or alternatively an increase in acquisition speed by more than a factor of 5x compared to conventional room temperature MRI radiofrequency (RF) coils. In combination with high magnetic fields, the MRI CryoProbe enables new pre-clinical neuroscience studies with functional MRI (fMRI).

A 2008 R&D 100 Award has been given to Bruker BioSpin (Billerica, MA, USA) for the MRI CryoProbe, as one of the 100 most technologically significant products introduced into the marketplace over the past year. Together with the 1.7-mm nuclear magnetic resonance (NMR) MicroCryoProbe, this results in two MR innovations from Bruker BioSpin being selected by the independent judging panel and editors of R&D magazine in 2008.

Bruker BioSpin's MRI CryoProbe technology uses cryogenic RF-coils and preamplifiers cooled by a closed-cycle helium gas refrigeration system. Bruker BioSpin is the pioneer in the development of cryogenic probes for high-resolution NMR. Over 650 Bruker NMR CryoProbes have been installed at customers worldwide so far. The new MRI CryoProbe is available for in vivo animal MRI at various field strengths for BioSpec, PharmaScan, and ClinScan MRI scanners.

Comprehensive animal studies using the MRI CryoProbe were performed at the ETH in Zurich, Switzerland, where it is routinely used for clinical neuroscience research on mice. Prof. Markus Rudin, director of the MRI and Optical Imaging Section of the Animal Imaging Center, ETH Zurich, commented, "this novel MRI CryoProbe technology has proven to provide a strong and impressive increase in sensitivity. It will greatly enhance the potential of MRI in small animals for clinical and pharmaceutical research.”

R&D Magazine is a resource geared for technologies and strategies for research and development based in Rockaway, NJ, USA.

Related Links:

Bruker BioSpin


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.